NCT00412256View on ClinicalTrials.gov

Omegaven in Patients With Rheumatoid Arthritis (ORA-Trial)

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

November 30, 2006

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Omegaven (10% fish-oil emulsion; Fresenius-Kabi)

Trial Locations (1)

A-2000

Center for Rheumatology Lower Austria, Humanisklinikum Lower Austria, Stockerau

All Listed Sponsors
lead

Humanis Klinikum Niederosterreich

OTHER

NCT00412256 - Omegaven in Patients With Rheumatoid Arthritis (ORA-Trial) | Biotech Hunter | Biotech Hunter